Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

S.P.F.P.L FINANCIERE PHARMACIE TLM : revenue, balance sheet and financial ratios

S.P.F.P.L FINANCIERE PHARMACIE TLM is a French company founded 3 years ago, specialized in the sector Gestion de fonds. Based in STRASBOURG (67200), this company of category PME shows in 2024 a net income positive of 322 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - S.P.F.P.L FINANCIERE PHARMACIE TLM (SIREN 923478234)
Indicator 2024 2023
Revenue N/C N/C
Net income 322 161 € -71 686 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2024, S.P.F.P.L FINANCIERE PHARMACIE TLM generates positive net income of 322 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

322 161 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1007%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1006.79%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

9.035%

Solvency indicators evolution
S.P.F.P.L FINANCIERE PHARMACIE TLM

Sector positioning

Debt ratio
1006.79 2024
2023
2024
Q1: 0.0
Med: 8.3
Q3: 92.95
Average +50 pts over 2 years

In 2024, the debt ratio of S.P.F.P.L FINANCIERE PHAR... (1006.79) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
9.04% 2024
2023
2024
Q1: 4.58%
Med: 48.37%
Q3: 87.3%
Average

In 2024, the financial autonomy of S.P.F.P.L FINANCIERE PHAR... (9.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of S.P.F.P.L FINANCIERE PHARMACIE TLM in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Based on 62 transactions of similar company sales in 2024, the value of S.P.F.P.L FINANCIERE PHARMACIE TLM is estimated at 2 381 174 € (range 676 077€ - 4 717 360€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
62 tx
676k€ 2381k€ 4717k€
2 381 174 € Range: 676 077€ - 4 717 360€
NAF 5 année 2024

Valuation method used

Net Income Multiple
322 161 € × 7.4x = 2 381 174 €
Range: 676 077€ - 4 717 361€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare S.P.F.P.L FINANCIERE PHARMACIE TLM with other companies in the same sector:

Voir toutes les statistiques du secteur Gestion de fonds

Frequently asked questions about S.P.F.P.L FINANCIERE PHARMACIE TLM

What is the revenue of S.P.F.P.L FINANCIERE PHARMACIE TLM ?

The revenue of S.P.F.P.L FINANCIERE PHARMACIE TLM is not publicly disclosed (confidential accounts filed with INPI).

Is S.P.F.P.L FINANCIERE PHARMACIE TLM profitable?

Yes, S.P.F.P.L FINANCIERE PHARMACIE TLM generated a net profit of 322 k€ in 2024.

Where is the headquarters of S.P.F.P.L FINANCIERE PHARMACIE TLM ?

The headquarters of S.P.F.P.L FINANCIERE PHARMACIE TLM is located in STRASBOURG (67200), in the department Bas-Rhin.

Where to find the tax return of S.P.F.P.L FINANCIERE PHARMACIE TLM ?

The tax return of S.P.F.P.L FINANCIERE PHARMACIE TLM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does S.P.F.P.L FINANCIERE PHARMACIE TLM operate?

S.P.F.P.L FINANCIERE PHARMACIE TLM operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.